Treatment of episcleritis. A double-blind trial comparing betamethasone 0.1 per cent, oxyphenbutazone 10 per cent, and placebo eye ointments.
AUTOR(ES)
Watson, P G
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1215234Documentos Relacionados
- Double-blind trial of the treatment of episcleritis-scleritis with oxyphenbutazone or prednisolone.
- Double-blind trial of dapsone against placebo in the treatment of rheumatoid arthritis.
- Topical betamethasone and hyaluronidase in the treatment of phimosis in boys: a double-blind, randomized, placebo-controlled trial
- Hyperbaric oxygen and multiple sclerosis: final results of a placebo-controlled, double-blind trial.
- Treatment of adenovirus infection of the eye with 5-iodo-2'-deoxyuridine. A double-blind trial.